CTOs on the Move

Jamaica Tourist Board

www.visitjamaica-usa.com

 
Jamaica Tourist Board is a Miami, FL-based company in the Business Services sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Walker Printing Co

Walker Printing Co is a Montgomery, AL-based company in the Business Services sector.

Esleeck Manufacturing Co

Esleeck Manufacturing Co is a Turners Falls, MA-based company in the Business Services sector.

GTandA Strategic Marketing

GT&A Strategic Marketing is a Minneapolis, MN-based company in the Business Services sector.

Nth Degree, Inc.

At Nth Degree we've always focused on you - our customer. Our website is all about you, our clients and the ever evolving trade show industry. But we wanted to take a page to show you of our company, our people and our history.

InnoCare Pharma 诺诚健华(HKEX: 09969; SSE: 688428)

InnoCare Pharma is a commercial stage biopharmaceutical company dedicated to discovering, developing, and commercializing best-in-class and/or first-in-class drugs for the treatment of cancer and autoimmune diseases. InnoCare has strong in-house innovation capabilities, holding multiple foreign and domestic patents with a rich product pipeline target liquid tumors, solid tumors, and autoimmune diseases. Our team has discovered and developed a strong pipeline. InnoCare was co-founded by Professor Shi Yigong, a world-renowned structural biologist, and Dr. Cui Jisong, an outstanding leader in the biopharmaceutical industry. We have over 1000 employees. Our core R&D staff brings rich experience from the worlds top pharmaceutical companies, such as Pfizer, GSK, Bristol-Myers Squibb, Merck, Johnson & Johnson, Bayer, etc. We are a truly global biopharmaceutical company with sites in Beijing, Nanjing, Shanghai, and Guangzhou, Hong Kong and Unites States. On March 23, 2020, InnoCare officially listed on the Hong Kong Stock Exchange (code: 9969). And on Sept. 21, 2023, InnoCare successfully got listed on STAR Board of Shanghai Stock Exchange (code: 688428). Our vision is to become a world-class biopharma leader to address the unmet medical needs globally.